Event Contact

Speaker Information

Dr. Shana Kelley is the President of the Chan Zuckerberg Biohub Chicago and the Neena B. Schwartz Professor at Northwestern in the Departments of Chemistry, Biomedical Engineering, and Biochemistry & Molecular Genetics.  The Kelley research group has pioneered new methods for tracking molecular and cellular analytes with unprecedented sensitivity.  Dr. Kelley’s work has been recognized with the ACS Inorganic Nanoscience Award, the Pittsburgh Conference Achievement Award, the Steacie Prize, an Alfred P. Sloan Research Fellowship, a Camille Dreyfus Teacher-Scholar award, a NSF CAREER Award, a Dreyfus New Faculty Award, and she was also named a “Top 100 Innovator” by MIT’s Technology Review.  Kelley is also a Guggenheim Fellow, a Fellow of the Royal Society of Canada, the Canadian Academy of Health Sciences, and the American Institute of Biological and Medical Engineering. She is an elected member of the American Academy of Arts and Sciences and the National Academy of Inventors. Her work is extensively cited and she has over 100 papers cited more than 100 times.  Kelley is an inventor on over 50 patents issued worldwide.  She is a founder of five life sciences companies, GeneOhm Sciences (acquired by Becton Dickinson in 2005), Xagenic Inc. (acquired by General Atomics in 2017), CTRL Therapeutics (founded in 2019), Arma Biosciences (founded in 2021) and Glimmer Therapeutics (founded in 2024).